Table 2 The clinical outcomes of COPD patients with eosinophilia
From: The association between eosinophilic exacerbation and eosinophilic levels in stable COPD
< 2% vs. ≥ 2 eosinophils | < 300 cells per µL vs. ≥ 300 cells per uL | |||||
|---|---|---|---|---|---|---|
Non-eosinophilic (n = 247) | Eosinophilic (n = 100) | P value | Non-eosinophilic (n = 299) | Eosinophilic (n = 48) | P value | |
Length of hospital stay (days) | 8.00 (6.00–13.00) | 6.00 (4.00–10.00) | < 0.001 | 8.00 (6.00–12.00) | 5.50 (3.25–9.50) | 0.001 |
ICU admission | 27 (10.9) | 3 (3.0) | 0.017 | 28 (9.4) | 2 (4.2) | 0.234 |
MV | 21 (8.5) | 3 (3.0) | 0.067 | 22 (7.4) | 2 (4.2) | 0.419 |
Duration of MV (days) | 5.50 (3.00–16.50) | 10.00 (0.00–33.00) | 0.829 | 5.00 (3.00–16.00) | 37.00 (10.00 – 33.00) | 0.142 |
Non-invasive ventilation | 5 (2.0) | 0 (0.0) | 0.152 | 5 (1.7) | 0 (0.0) | 0.367 |
Treatment results | ||||||
Resolve | 235 (95.1) | 98 (98.0) | 0.220 | 286 (95.7) | 47 (97.9) | 0.459 |
Mortality | 12 (4.9) | 2 (2.0) | 0.220 | 13 (4.3) | 1 (2.1) | 0.459 |
Death within | ||||||
28 days | 7 (2.8) | 0 (0.0) | 0.089 | 7 (2.3) | 0 (0.0) | 0.284 |
Death after | ||||||
28 days | 5 (2.0) | 2 (2.0) | 0.988 | 6 (2.0) | 1 (2.1) | 0.972 |